ENTITY
Shanghai Henlius Biotech

Shanghai Henlius Biotech (2696 HK)

149
Analysis
Health CareChina
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
Publication Icon
No publications yet
There aren’t any Insights right now
Back to "All"
x